14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $5.91 $5.91 Wednesday, 17th Aug 2022 EDGE stock ended at $5.91. During the day the stock fluctuated 0% from a day low at $5.91 to a day high of $5.91.
90 days $5.91 $5.91
52 weeks $4.60 $17.85

Historical Edge Therapeutics prices

Date Open High Low Close Volume
Jun 06, 2022 $5.91 $5.91 $5.91 $5.91 0
Jun 03, 2022 $5.91 $5.91 $5.91 $5.91 0
Jun 02, 2022 $5.91 $5.91 $5.91 $5.91 0
Jun 01, 2022 $5.91 $5.91 $5.91 $5.91 0
May 31, 2022 $5.91 $5.91 $5.91 $5.91 0
May 27, 2022 $5.91 $5.91 $5.91 $5.91 0
May 26, 2022 $5.91 $5.91 $5.91 $5.91 0
May 25, 2022 $5.91 $5.91 $5.91 $5.91 0
May 24, 2022 $5.91 $5.91 $5.91 $5.91 0
May 23, 2022 $5.91 $5.91 $5.91 $5.91 0
May 20, 2022 $5.91 $5.91 $5.91 $5.91 0
May 19, 2022 $5.91 $5.91 $5.91 $5.91 0
May 18, 2022 $5.91 $5.91 $5.91 $5.91 0
May 17, 2022 $5.91 $5.91 $5.91 $5.91 0
May 16, 2022 $5.91 $5.91 $5.91 $5.91 0
May 13, 2022 $5.91 $5.91 $5.91 $5.91 0
May 12, 2022 $5.91 $5.91 $5.91 $5.91 0
May 11, 2022 $5.91 $5.91 $5.91 $5.91 0
May 10, 2022 $5.91 $5.91 $5.91 $5.91 0
May 09, 2022 $5.91 $5.91 $5.91 $5.91 0
May 06, 2022 $5.91 $5.91 $5.91 $5.91 0
May 05, 2022 $5.91 $5.91 $5.91 $5.91 0
May 04, 2022 $5.91 $5.91 $5.91 $5.91 0
May 03, 2022 $5.91 $5.91 $5.91 $5.91 0
May 02, 2022 $5.91 $5.91 $5.91 $5.91 0
Click to get the best stock tips daily for free!

About Edge Therapeutics

Edge Therapeutics, Inc., a clinical-stage biotechnology company, discovers, develops, and commercializes hospital-based therapies for acute life-threatening neurological conditions. Its lead product includes EG-1962, a polymer-based microparticle used for the treatment of aneurysmal subarachnoid hemorrhage. The company also develops EG-1964 for the management of chronic subdural hematoma as a prophylactic treatment to prevent recurrent bleeding. ... EDGE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT